Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ford Motor Company (F) vs Cassava Sciences Inc (FLNA) Price & Performance

Ford Motor CompanyTrade
Cassava Sciences IncTrade

Price performance (Past 24H)

Key statistics

Ford Motor Company vs Cassava Sciences Inc — how do they compare? Ford Motor Company trades at $13.98 (market cap $55.83B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: Ford Motor Company is far larger — about 1169.2× Cassava Sciences Inc's market cap, and Ford Motor Company pays a 4.29% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.

FFLNA
Market Cap
$55.83B$47.75M
Sector
Consumer CyclicalHealth
52-Week High
$17.44$4.64
52-Week Low
$11.14$0.87
Enterprise Value
$187.79B-$34.93M
Dividend Yield
4.29%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ford Motor Company

Ford (F) trades at $13.98, up 1.38% with a bullish technical signal despite mixed fundamentals. The company reported negative net income of -$8.18B in 2025 but maintains strong operating cash flow of $21.28B. Recent news highlights Ford's new $28,350 Fathom EV truck launch for 2027, targeting affordable electric vehicles while managing EV transition costs through its profitable commercial Pro segment.

Outlook remains cautious with analyst consensus at $16.00 (43% buy ratings). Key opportunities include EV expansion and dividend stability ($0.15 quarterly), while risks involve persistent net losses, high debt levels (56.49% debt-to-asset), and competitive EV market pressures. The stock offers value with low P/E (11.84) but requires monitoring of profitability turnaround.

Cassava Sciences Inc

FLNA trades at $0.995, up 3.75% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported three consecutive quarterly earnings beats, with Q2 2026 EPS of -$0.18 beating expectations of -$0.225. Financials show negative cash flows and profitability, with ROE at -55.79% and net income of -$90.97M in 2025. Analyst consensus is strongly positive with 8 buy ratings out of 12.

Despite operational losses, FLNA's consistent earnings beats and strong analyst support suggest potential upside if clinical developments progress. Key risks include sustained cash burn, lack of revenue, and dependence on successful drug trials for Tuberous Sclerosis Complex. The stock remains speculative with high volatility expected.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Ford Motor Company

Ford Motor Company designs, manufactures, and services cars and trucks. The Company also provides vehicle-related financing, leasing, and insurance through its subsidiary.

Read more on F

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA